Antisense mapping KOR-1: Evidence for multiple kappa analgesic mechanisms

Brain Research

Volumn 826, Issue 2, 1999, Pages 289-292

  Pasternak, Katie R ^a   Rossi, Grace C ^a   Zuckerman, Amy ^a   Pasternak, Gavril W ^a  

^a Department of Neurology   (United States)

Author keywords

Neoendorphin; Analgesia; Antisense mapping; Dynorphin B; Kappa; Kappa(l) receptor; Opioid

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALPHA NEOENDORPHIN; BINALTORPHIMINE; DYNORPHIN B; KAPPA OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXON; GENE MAPPING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCORING SYSTEM; SEQUENCE ANALYSIS;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTISENSE ELEMENTS (GENETICS); BINDING SITES; CHROMOSOME MAPPING; DYNORPHINS; ENDORPHINS; ION CHANNEL GATING; MALE; MICE; MICE, INBRED ICR; PROTEIN PRECURSORS; RECEPTORS, OPIOID, KAPPA;

EID: 0033134780     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01294-9     Document Type: Article

References (16)

1. Chavkin C., James I.F., Goldstein A. Dynorphin is a specific endogenous ligand of the κ-opioid receptor. Science. 215:1982;413-415.
2. Chien C.-C., Brown G., Pan Y.-X., Pasternak G.W. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor. Eur. J. Pharmacol. 253:1994;R7-R8.
3. 3 subtype. J. Pharmacol. Exp. Ther. 251:1989;461-468.
4. Goldstein A., Tachibana S., Lowney L.I., Hunkapiller M., Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA. 76:1979;6666-6670.
5. Martin W.R. Opioid antagonists. Pharmacol. Rev. 19:1967;463-521.
6. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
7. 3-related opioid receptor. Mol. Pharmacol. 47:1995;1180-1188.
8. Pasternak G.W., Standifer K.M. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16:1995;344-350.
9. Portoghese P.S., Lipkowski A.W., Takemori A.E. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor agonists. Life Sci. 40:1987;1287-1292.
10. 3H ]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable μ opiate Mol. Pharmacol. 35:1989;67-74.
11. Reisine T., Bell G.I. Molecular biology of opioid receptors. Trends Neurosci. 16:1993;506-510.
12. Rossi G.C., Brown G.P., Leventhal L., Yang K., Pasternak G.W. Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia. Neurosci. Lett. 216:1996;1-4.
13. Rossi G.C., Pan Y.-X., Brown G.P., Pasternak G.W. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett. 369:1995;192-196.
14. Rothman R.B., Bykov V., DeCosta B.R., Jacobson A.E., Rice K.C., Brady L.S. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides. 11:1990;311-317.
15. Standifer K.M., Jenab S., Su W., Chien C.-C., Pan Y.-X., Inturrisi C.E., Pasternak G.W. Antisense oligodeoxynucleotides to the cloned δ receptor, DOR-1: uptake, stability and regulation of gene expression. J. Neurochem. 65:1995;1981-1987.
16. 2 opioid receptors. Proc. Natl. Acad. Sci. USA. 85:1988;4061-4065.